SCHEMBL19452136

SCHEMBL19452136

CCc1cc(C)nc2c(C(=O)NC3CCCCC3)ccn12

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.54
POLB P06746 4/20 0.54
KDM4E B2RXH2 3/20 0.54
HPGD P15428 2/20 0.50
RAB9A P51151 1/20 0.48
ATM Q13315 1/20 0.47
CNR1 P21554 2/20 0.47
CNR2 P34972 2/20 0.47
HSD17B10 Q99714 1/20 0.47
F12 P00748 1/20 0.46
LMNA P02545 2/20 0.45
GLA P06280 1/20 0.45
MAPK1 P28482 1/20 0.45
MAPT P10636 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
MEN1 O00255 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C19 P33261 1/20 0.44
KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19452132 0.88 ALDH1A1 (0.51) ALDH1A1POLBKDM4EHPGDRAB9A
SCHEMBL20353019 0.86 ALDH1A1 (0.64) ALDH1A1POLBKDM4EHPGDRAB9A
SCHEMBL18356836 0.86 ALDH1A1 (0.64) ALDH1A1POLBKDM4EHPGDRAB9A
SCHEMBL19368286 0.86 ALDH1A1 (0.64) ALDH1A1POLBKDM4EHPGDRAB9A
SCHEMBL20353021 0.86 ALDH1A1 (0.64) ALDH1A1POLBKDM4EHPGDRAB9A
SCHEMBL23511774 0.86 ALDH1A1 (0.64) ALDH1A1POLBKDM4EHPGDRAB9A
SCHEMBL19452135 0.85 CRHR1 (0.40) ALDH1A1POLBKDM4EHPGDRAB9A
SCHEMBL21460966 0.85 CRHR1 (0.40) ALDH1A1POLBKDM4EHPGDRAB9A
SCHEMBL19452131 0.83 ALDH1A1 (0.40) ALDH1A1POLBKDM4EHPGDRAB9A
SCHEMBL21757540 0.83 ALDH1A1 (0.55) ALDH1A1POLBKDM4EHPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017176962-A1 PYRROLO[1,2-A]PYRIMIDINYL CARBOXAMIDE COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS LYSOSOMAL THERAPEUTICS, INC. (US) 2017-10-12 WO disclosed